These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 32088543)

  • 41. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia.
    Chang CJ; Ryan PB; Smarr MM; Kannan K; Panuwet P; Dunlop AL; Corwin EJ; Barr DB
    Environ Res; 2021 Jul; 198():110445. PubMed ID: 33186575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perfluoroalkyl substances exposure and hearing impairment in US adults.
    Ding N; Park SK
    Environ Res; 2020 Aug; 187():109686. PubMed ID: 32474307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Hypertension May Be Attenuated by Endogenous Sex Hormones: A Nationally Representative Cross-Sectional Study.
    Wu B; Sheng N; Li Z; Wang J; Ji S; Zhao F; Pan Y; Qu Y; Wei Y; Xie L; Li Y; Hu X; Wu C; Zhang Z; Qiu Y; Zheng X; Zhang W; Hu X; Song H; Cai J; Cao Z; Ji JS; Lv Y; Dai J; Shi X
    Hypertension; 2024 Aug; 81(8):1799-1810. PubMed ID: 38853753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
    Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
    Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003-16): an observational study.
    Zhang Y; Mustieles V; Wang YX; Sun Y; Agudelo J; Bibi Z; Torres N; Oulhote Y; Slitt A; Messerlian C
    Lancet Planet Health; 2023 Jun; 7(6):e449-e458. PubMed ID: 37286242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Examining the impact of polyfluoroalkyl substance exposure on erythrocyte profiles and its related nutrients: Insights from a prospective study on young Taiwanese.
    Lin CY; Lee HL; Wang C; Sung FC; Su TC
    Environ Pollut; 2024 Oct; 359():124576. PubMed ID: 39032552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exposure to per- and polyfluoroalkyl substances and glycemic control in older US adults with type 2 diabetes mellitus.
    Brosset E; Ngueta G
    Environ Res; 2023 Jan; 216(Pt 3):114697. PubMed ID: 36334831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perfluoroalkyl substances are inversely associated with coronary heart disease in adults with diabetes.
    Honda-Kohmo K; Hutcheson R; Innes KE; Conway BN
    J Diabetes Complications; 2019 Jun; 33(6):407-412. PubMed ID: 30928231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Associations between per- and polyfluoroalkyl substances, liver function, and daily alcohol consumption in a sample of U.S. adults.
    Ma X; Fisher JA; VoPham T; Vasiliou V; Jones RR
    Environ Res; 2023 Oct; 235():116651. PubMed ID: 37451576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
    Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
    Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
    Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population.
    Lind PM; Lind L; Salihovic S; Ahlström H; Michaelsson K; Kullberg J; Strand R
    Environ Res; 2022 Jun; 209():112677. PubMed ID: 35074350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
    Ye X; Kato K; Wong LY; Jia T; Kalathil A; Latremouille J; Calafat AM
    Int J Hyg Environ Health; 2018 Jan; 221(1):9-16. PubMed ID: 28993126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Associations of exposure to perfluoroalkyl substances with serum uric acid change and hyperuricemia among Chinese women: Results from a longitudinal study.
    Feng Y; Fu M; Guan X; Wang C; Meng H; Zhou Y; He M; Guo H
    Chemosphere; 2022 Dec; 308(Pt 3):136438. PubMed ID: 36116625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: A multi-cohort study.
    Beglarian E; Costello E; Walker DI; Wang H; Alderete TL; Chen Z; Valvi D; Baumert BO; Rock S; Rubbo B; Aung MT; Gilliland FD; Goran MI; Jones DP; McConnell R; Eckel SP; Conti DV; Goodrich JA; Chatzi L
    Environ Res; 2024 Mar; 244():117611. PubMed ID: 38061983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
    Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
    Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First trimester plasma PER- AND Polyfluoroalkyl Substances (PFAS) and blood pressure trajectories across the second and third trimesters of pregnancy.
    Burdeau JA; Stephenson BJK; Aris IM; Preston EV; Hivert MF; Oken E; Mahalingaiah S; Chavarro JE; Calafat AM; Rifas-Shiman SL; Zota AR; James-Todd T
    Environ Int; 2024 Apr; 186():108628. PubMed ID: 38583297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Demographic, life-style and physiological determinants of serum per- and polyfluoroalkyl substance (PFAS) concentrations in a national cross-sectional survey of Swedish adolescents.
    Nyström J; Benskin JP; Plassmann M; Sandblom O; Glynn A; Lampa E; Gyllenhammar I; Moraeus L; Lignell S
    Environ Res; 2022 May; 208():112674. PubMed ID: 34998808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.